A risk management program aimed at preventing fetal exposure to isotretinoin: Retrospective cohort study
Authors:
- T. Craig CheethamTCT. Craig Cheetham
- Linda WongLWLinda Wong
- 1 September 2006
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 55 (3) , 442-448
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Trends in Adherence to a Revised Risk Management Program Designed to Decrease or Eliminate Isotretinoin-Exposed Pregnancies: Evaluation of the Accutane SMART ProgramYearbook of Dermatology and Dermatologic Surgery, 2006
- A survey of pregnant women using isotretinoinBirth Defects Research Part A: Clinical and Molecular Teratology, 2005
- Changes in isotretinoin prescribing before and after implementation of the System to Manage Accutane Related Teratogenicity™ (SMART™) risk management programPharmacoepidemiology and Drug Safety, 2005
- Trends in Adherence to a Revised Risk Management Program Designed to Decrease or Eliminate Isotretinoin-Exposed PregnanciesArchives of Dermatology, 2005
- Congenital Oculomotor Nerve Synkinesis Associated Wwith Fetal Retinoid SyndromeJournal of American Association for Pediatric Ophthalmology and Strabismus, 2005
- Continued Occurrence of Accutane®-Exposed PregnanciesObstetrical & Gynecological Survey, 2002
- Continued occurrence of Accutane®‐exposed pregnanciesTeratology, 2001
- Multiple Temporal Bone Anomalies in Isotretinoin SyndromeJAMA Otolaryngology–Head & Neck Surgery, 1999
- Terminations of Pregnancy for Exposure to Oral Retinoids in South Australia, 1985–1993Australian and New Zealand Journal of Obstetrics and Gynaecology, 1995
- A Pregnancy-Prevention Program in Women of Childbearing Age Receiving IsotretinoinNew England Journal of Medicine, 1995